Search Results - Blohmer, J. -U.
- Showing 1 - 5 results of 5
-
1
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-n... by Meyer-Wilmes, Philipp (Author) , Huober, Jens (Author) , Untch, Michael (Author) , Blohmer, J. -U. (Author) , Janni, W. (Author) , Denkert, Carsten (Author) , Klare, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Bayer, C. (Author) , Reinisch, M. (Author) , Bjelic-Radisic, V. (Author) , Zahm, Dirk-Michael (Author) , Hanusch, Claus Alexander (Author) , Solbach, C. (Author) , Heinrich, G. (Author) , Hartkopf, A. D. (Author) , Schneeweiss, Andreas (Author) , Fasching, Peter Andreas (Author) , Filmann, N. (Author) , Nekljudova, V. (Author) , Holtschmidt, J. (Author) , Stickeler, E. (Author) , Loibl, Sibylle (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response by Loibl, Sibylle (Author) , Schneeweiss, Andreas (Author) , Huober, J. (Author) , Braun, M. (Author) , Rey, J. (Author) , Blohmer, J. -U. (Author) , Furlanetto, J. (Author) , Zahm, D. -M. (Author) , Hanusch, C. (Author) , Thomalla, J. (Author) , Jackisch, C. (Author) , Staib, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Solbach, C. (Author) , Fasching, P. A. (Author) , Nekljudova, V. (Author) , Denkert, C. (Author) , Untch, M. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) by Fasching, Peter Andreas (Author) , Link, T. (Author) , Hauke, J. (Author) , Seither, F. (Author) , Jackisch, C. (Author) , Klare, P. (Author) , Schmatloch, S. (Author) , Hanusch, C. (Author) , Huober, J. (Author) , Stefek, A. (Author) , Seiler, S. (Author) , Schmitt, W. D. (Author) , Uleer, C. (Author) , Doering, G. (Author) , Rhiem, K. (Author) , Schneeweiss, Andreas (Author) , Engels, K. (Author) , Denkert, C. (Author) , Schmutzler, R. K. (Author) , Hahnen, E. (Author) , Untch, M. (Author) , Burchardi, N. (Author) , Blohmer, J. -U. (Author) , Loibl, S. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
4
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo by Karn, Thomas (Author) , Denkert, C. (Author) , Weber, K. E. (Author) , Holtrich, U. (Author) , Hanusch, C. (Author) , Sinn, B. V. (Author) , Higgs, B. W. (Author) , Jank, P. (Author) , Sinn, Peter (Author) , Huober, J. (Author) , Becker, C. (Author) , Blohmer, J. -U. (Author) , Marmé, Frederik (Author) , Schmitt, W. D. (Author) , Wu, S. (Author) , van Mackelenbergh, M. (Author) , Müller, V. (Author) , Schem, C. (Author) , Stickeler, E. (Author) , Fasching, P. A. (Author) , Jackisch, C. (Author) , Untch, M. (Author) , Schneeweiss, Andreas (Author) , Loibl, S. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
5
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto by Loibl, Sibylle (Author) , Weber, K. E. (Author) , Timms, K. M. (Author) , Elkin, E. P. (Author) , Hahnen, K. (Author) , Fasching, P. A (Author) , Lederer, B. (Author) , Denkert, A. (Author) , Schneeweiss, Andreas (Author) , Braun, S (Author) , Salat, C. T. (Author) , Rezai, M. (Author) , Blohmer, J. U. (Author) , Zahm, D. M. (Author) , Jackisch, B (Author) , Gerber, Bernd (Author) , Klare, P. (Author) , Kümmel, S (Author) , Schem, C. (Author) , Paepke, S. (Author) , Schmutzler, R. (Author) , Rhiem, K. (Author) , Penn, S. (Author) , Reid, J. (Author) , Nekljudova, V. (Author) , Hartman, A.-R. (Author) , Minckwitz, von G. (Author) , Untch, M. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
survival
HER2-negative
HER2-negative breast cancer
HRD
PARP inhibitor
breast cancer
cabazitaxel
carboplatinum
checkpoint inhibitor
durvalumab
early triple-negative breast cancer
exome sequencing
neoadjuvant chemotherapy
neoadjuvant immune checkpoint inhibition
neoadjuvant therapy
olaparib
paclitaxel
triple negative breast cancer
tumor mutational burden